GB2034305A - Preparation of piperidine derivatives - Google Patents

Preparation of piperidine derivatives Download PDF

Info

Publication number
GB2034305A
GB2034305A GB7936701A GB7936701A GB2034305A GB 2034305 A GB2034305 A GB 2034305A GB 7936701 A GB7936701 A GB 7936701A GB 7936701 A GB7936701 A GB 7936701A GB 2034305 A GB2034305 A GB 2034305A
Authority
GB
United Kingdom
Prior art keywords
prepare
urea
piperid
radical
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7936701A
Other versions
GB2034305B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IE2100/78A external-priority patent/IE47461B1/en
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Publication of GB2034305A publication Critical patent/GB2034305A/en
Application granted granted Critical
Publication of GB2034305B publication Critical patent/GB2034305B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a new process for the preparation of compounds of value as pharmaceuticals or intermediates. The process comprises a process for preparing compounds of formula I <IMAGE> and acid addition salts thereof, wherein R is alkyl, cycloalkyl, aralkyl or aryl (including heteroaryl), R<1> is an organic radical, X is oxygen or sulphur and A is an alkylene, mono- or dioxo- or hydroxyalkylene radical of 1-5 carbon atoms, which process comprises reacting a compound of formula II <IMAGE> wherein R<1> and A are as defined above with an acylurea of formula H2NCXNHCOR wherein R is as defined above and X is oxygen or sulphur and if desired converting the product to an acid addition salt.

Description

SPECIFICATION Preparation of piperidine derivatives The invention relates to a new process for preparing acyl urea and thiourea derivatives.
In United Kingdom Patent Specifications 1 425 354 and 1 459 506 there are described novel piperidine derivatives which have a ureido or thioureido group, usually at the 4- position of the piperidine ring. One of the preferred substituents of this ureido orthioureido group is an acyl especially a benzoyl group. The preferred way of making the acyl ureido and thioureido compounds of the above mentioned specifications is to react the appropriate 4-amino-i -substituted-piperidine with an acylisocyanate or an acylisothiocyanate, for example benzoyl isocyanate.
This reaction can give variable yields. Also it is difficult to obtain good quality benzoylisocyanate which is an unstable compound which readily reacts with moisture in the atmosphere.
It has been known since 1954 that primary long chain amines can react with urea to give the corresponding alkylureas (see Erickson J.A.C.S.
1954, 3977). As described in this reference the reaction can give a variety of products namely alkylureas, 1,3-dialkylureas, l-alkyl-biurets, 1,3- dialkylbiurets and 1,5-dialkylbiurets.
It has now been found that acylureido or acylthioureido compounds of the above mentioned UK patent specification can be prepared in good yield by reacting the appropriate 4-amino-i -substituted-piperidine with an acylurea or acylthiourea, e.g. benzoylurea. This reaction may be used to prepare compounds of United Kingdom Specifications 1 425 354 and 1 459 506 and also intermediates for these compounds such as 1-(1 -benzylpiperid-4-yl)-3- benzoylurea. The yields in the process of this invention are in general remarkably high.
Accordingly the invention provides a process for preparing compounds of formula I
and acid addition salts thereof wherein R is alkyl, cycloalkyl, aralkyl, or aryl (including heteroaryl), R' is an organic radical, X is oxygen or sulphur and A is an alkylene, mono- or dioxo- or hydroxyalkylene radical of 1-5 carbon atoms, which process comprises reacting a compound of formula II
wherein R' and A are as defined above with an acylurea of formula H2NCXNHCOR wherein R is as defined above and X is oxygen or sulphur and if desired converting the product to an acid addition salt.
The process of the invention may be performed in the absence of solvent but is usually carried out by heating the reactants in the presence of a suitable inert organic solvent, for example toluene, pyridine, xylene, chlorobenzene, dimethylformamide or dioxan. Pyridine is the preferred solvent. Often it is convenient to reflux the reactants in the solvent until the reaction is complete. High yields e.g. 80-90% can be obtained. Preferably the solvent has a boiling point greater than 1000C.
It is preferred to use equimolar amounts of the reactants.
When group R is an alkyl radical it is preferably lower alkyl of 1 to 6 carbon e.g. methyl, ethyl, npropyl, isopropyl, n-butyl or isobutyl, pentyl or hexyl. When R is aryl it may be carbocyclic aryl or heterocyclic aryl. Preferred aryl groups are phenyl which may be substituted e.g. by halogen or lower alkoxy. The preferred heteroaryl group is thenyl.
The preferred cycloalkyl groups are those having from 5 to 7 carbon atoms e.g. cyclohexyl.
The group R' may be an aryl group especially phenyl or substituted phenyl, for example as described in United Kingdom Specification 1 459 506. The substituents include halogen, e.g.
fluorine or chlorine, lower alkoxy, e.g. methoxy, aryl lower alkoxy, e.g. benzyloxy, hydroxy, lower alkyl e.g. methyl, alkylenedioxy, e.g.
methylenedioxy, or trihalo lower alkyl, e.g.
trifluoromethyl.
The term "lowef' in relation to alkyl and alkoxy radicals used herein means that the radical contains from 1 to 6 carbon atoms. Usually such radicals containing from 1 to 4 carbon atoms are preferred.
R' may be an indolyl radical such as described in United Kingdom Patent Specification 1,425,354. The indolyl radical-may have the formula Ill
Wherein R2 represents hydrogen, lower alkyl, or aryi, R3 represents hydrogen, halogen, lower alkoxy, aryl lower alkoxy, hydroxy or lower alkyl and R4 represents hydrogen, lower alkyl, aryl lower alkyl or arnyl.
The process of this invention may also be used to prepare compounds wherein R' is a 1,4benzodioxan-2-yl group such as those described in United Kingdom Patent Application No. 51 781/76 and cognate 45142/77.
The 1 ,4-benzodioxan-2-yl group may have the formula
wherein R5 represents, hydrogen, halogen, lower alkyl, or lower alkoxy.
Furthermore the process of the invention may be used to prepare compounds wherein R' is of formula V
wherein R6 is hydrogen or lower alkyl, and R7 is hydrogen, halogen, lower alkyl or lower alkoxy.
Compounds of this type are described in United Kingdom Patent Application 51781/76 and cognate 45142/77.
The alkylene radical A may be a straight chain or branched and when A is branched it is preferably a straight chain alkylene containing up to 4 carbon atoms in the chain and carrying one methyl substituent. Examples for the alkylene chain A are described in U.K. Patent Specification No. 1 425 354. When R1 is of formula V then A preferably has formula CHOHCH2 or COCH2.
The products of the process of the invention are generally pharmaceuticals as described in U.K.
Patent Specification 1 425 354, 1 459 506 or 1 494 805 or United Kingdom Patent Applications Serial Nos.51781/76 and 45142/77.
However, certain products are intermediates e.g. those in which R' is a phenyl and A is -CH2-. These compounds can be hydrogenolysed to remove the benzyl group giving a piperidine which is an intermediate for preparing compounds of United Kingdom specifications 1 425 354 or 1 459 506 by routes described in these Specifications.
The acid addition salts include those formed from organic and inorganic acids e.g. sulphates, hydrochlorides, hydrobromides, hydroiodides, nitrates, phosphates, sulphonates (e.g. methane and p-toluene sulphonates), acetates, maleates, fu ma rates, ta rtrates, and formats.
The invention is illustrated by the following examples.
EXAMPLE 1 Preparation of I-II -Benzylpiperid-4-yll-3- benzoylurea A solution of benzoylurea (0.82 g, 5 mmol) and 4-amino-1-benzylpiperidine (0.95 g, 5 mmol) in pyridine (4 cm3) was heated under reflux for 2.5 hours. The solution was then poured into water and the precipitated product collected by filtration, washed well with water, and dried to give the title compound 1.55 g (92%) m.p. 180-810C.This product is an intermediate for 1 -(piperid-4-yl)-3benzoyl urea.
EXAMPLE 2 7 -(1 -Benzylpiperid-4-ylJ-3-(3- methoxybenzoyl)urea A solution of m-methoxybenzoylurea (9.7 g, 0.05 mol) and 4-amino-1 -benzylpiperidine (9.5 g, 0.05 mol) in pyridine (40 cm3) was heated under reflux for 3 hours. The solution was then poured into water (100 cm3), cooled in ice, and the precipitated product collected by filtration, washed with water, and dried to give the title compound (17.7 g, 94%). A sample crystallised from ethanol gave m.p. 1 49-500C. The product is an intermediate for 1-(piperid-4-ly)-3-(3- methoxybenzoyl)urea.
EXAMPLE 3 1 -Benzoyl-3-( 1 -[2-(indoi-3-yI)ethyllpiperid-4- yi)urea A solution of 4-amino-1 -(2 [indol3-yl]ethyl)- piperidine (1.21 g, 5 mmol) and benzoylurea (0.82 g, 5 mmol) in pyridine (4 cm3) was heated under reflux for 3 hours. The solution was then diluted with water and the precipitated product collected by filtration washed with water and dried to give the title compound (1.6 9,87%). The base was suspended in hot ethanol (30 cm3) and acidified with ethanolic hydrogen chloride to precipitate the hydrochloride. Recrystallisation from aqueous methanol (80% methanol) gave 1.07 g (50.5%) m.p. 260-61 OC.
EXAMPLE 4 1 -Benzoyl-3-( 1 -[4-oxo-4-phenylbutylipiperid-4- vi) urea Reaction of 4 amino-1 -(4-oxo-phenylbutyl)piperidine (1.5 g, 5 mmol) with benzoylurea (0.82 g, 5 mmol) following the procedure of example 3 gave (1.7 g, 91%) of the title compound.
Conversion to the hydrochloride and recrystallisation as in example 3 gave 1.47 g (68.5%) m.p209-1 10C.
EXAMPLE 5 1 -Benzo yi-3-( 1 -[indol-3-ylmethylipiperid-4- yl)urea Reaction of 4-amino-1-(indol-3-ylmethyl)- piperidine. (1.14 g, 5 mmol) with benzoylurea (0.82 g, 5 mmol) following the procedure of example 3 gave (1.5 9,79%) of the title compound. Conversion to the hydrochloride with ethanolic hydrogen chloride gave 0.55 (37.5%) m.p. 260--62 OC.
EXAMPLE 6 1 -(1 -Benzylpiperid-4-yl)-3-benzoylurea A solution of benzoylurea (0.82 g, 5 mmol) and 4-amino-l -benzylpiperidine (0.95 g, 5 mmol) in toluene (20 cm3) was heated under reflux for 7 hours to give a clear solution. (The reaction was shown to be complete by t.l.c.). The solution was cooled in ice and the precipitated title compound collected by filtration 1.35 g (80%).
EXAMPLE 7 1 -Benzoyl-3-[(2-(indol-3- -(2-(indoA3W)-ethWfpIpefld-4- yl]thiourea A solution of 4-amino-l -(2-[indol-3-yl]- ethyl)piperidine (1 mol) and benzoylthiourea (1 mol) in xylene is heated under reflux for several hours. The solution is cooled in ice and the title compound filtered off.
EXAMPLE 8 1 -(2-Thenoyi)-3-[1 -r2-[3-indolyl]ethyl)piperid- 4-yllurea A solution of 4-a mino-l -(2-[indol-3 yl]ethyl)piperidine (1 mol) and thenoylurea (1 mol) in dimethylformamide is heated under reflux for several hours until formation of the title compound is complete as shown by t.l.c. The solution is cooled, poured into water and the title compound is filtered off and dried.
EXAMPLE 9 1 -Cyclohexanecarbonyl-3-[1 -(2-[3 indolyllethyl)piperid-4-yl]urea.
A solution of 4-amino-1 -(2-[indol-3 yl]ethyl)piperidine (1 mol) and cyclohexanecarbonylurea (1 mol) in pyridine is heated under reflux until formation of the title compound is complete. The solution is cooled, poured into water and the title compound is filtered off and dried.
EXAMPLE 10 1 -(4-Chiorohenzoyi)-3-( 1 -[indol-3- ylmethylipiperid-4-yl)urea A mixture of 4-amino-i(indol-3- ylmethyl)piperidine (1.5 g, 6.5 mmol), 4 chlorobenzoylurea (1 g, 5 mmol) and pyridine (4 cm3) was heated under reflux for 3 hours. The mixture was then poured into water and the precipitated product collected by filtration washed with water and dried to give the title compound as the free base. The base was then suspended in warm ethanol and acidified with ethanolic hydrogen chloride to give a clear solution which crystallised after ice cooling to give the hydrochloride. This was recrystallised twice from methanol to give the hydrochloride mp 269-271 0C.
Analysis: Found: C, 58.74; H, 5.65; N, 12.68% C22H23CIN402.Hcl requires C, 59.07; H,5.18; N, 12.52%.
EXAMPLE 11 1 -Benzoyl-3-/ 1 -(2-( I ,4-benzodioxan-2- yi)- oxoethyi]piperid-4- yllurea.
A mixture of benzoylurea (1 mol) and 4-amino1 -(2-( 1 ,4-benzodioxan-2-yl)2-oxoethyl)piperidine (1 mol) in dimethylformamide is heated under reflux for several hours. Water is added, the title compound precipitates and is filtered off and dried.
EXAMPLE 12 1 -Renzoyl-3-[1 -K2-hydroxy-3-[2- methoxyphenoxylpropyl)-piperid-4-yl]urea.
A mixture of benzoylurea (1 mol) and 4-amino 1 -(2-hydroxy-3-[methoxyphenoxy| propyl)piperidine (1 mol) in pyridine is refluxed for several hours until formation of the title compound is complete as shown by t.l.c. The resulting solution is poured into water and the title compound filtered off and dried.

Claims (31)

1. A process for preparing compounds of formula I
and acid addition salts thereof, wherein R is alkyl, cycloalkyl, aralkyl or aryl (including heteroaryl), R1 is an organic radical, X is oxygen or sulphur and A is an alkylene, mono- or dioxo- or hydroxyalkylene radical of 1-5 carbon atoms, which process comprises reacting a compound of formula II
wherein R' and A are as defined above with an acylurea of formula H2NCXNHCOR wherein R is as defined above and X is oxygen or sulphur and if desired converting the product to an acid addition salt.
2. A process as claimed in Claim 1, wherein R1 is an indolyl radical.
3. A process as claimed in Claim 2, wherein the indolyl radical has the formula Ill
wherein R2 represents hydrogen, lower alkyl, or aryl, R3 represents hydrogen, halogen, lower alkoxy, aryl lower alkoxy, hydroxy or lower alkyl and R4 represents hydrogen, lower alkyl, aryl lower alkyl or aroyl.
4. A process as claimed in Claim 1, wherein R1 represents a carbocyclic aryl radical.
5. A process as claimed in Claim 4 wherein R1 represents a substituted or unsubstituted phenyl radical.
6. A process as claimed in Claim 5, wherein R1 represents phenyl substituted by halogen, lower alkoxy, aryllower alkoxy, hydroxy, lower alkyl, alkylenedioxy or trihalo-lower alkyl.
7. A process as claimed in Claim 1, wherein R1 represents a 1 ,4-benzodioxan-2-yl radical.
8. A process as claimed in Claim 7, wherein the 1 ,4-benzodioxan-2-yl radical has the formula (lV)
wherein R5 represents hydrogen, halogen, lower alkyl or lower alkoxy.
9. A process as claimed in Claim 1, wherein R1 represents a radical of formula V.
wherein R5 is hydrogen or lower alkyl, and R7 is hydrogen, halogen, lower alkyl or lower alkoxy.
10. A process as claimed in any one of claims 1 to 6 wherein A is -CH2-.
11. A process as claimed in Claim 7, 8 or 9, wherein A is CHOHCH2- or -COCH2-.
12. A process as claimed in any one of the preceding claims wherein R is phenyl, halophenyl or lower alkoxyphenyl.
13. A process as claimed in any one of Claims 111, wherein R isthenyl.
14. A process as claimed in any one of Claims 1-11, wherein R is cyclohexyl.
15. A process as claimed in Claim 1 when used to prepare 1 -(1 -benzylpiperid-4-yl)-3-benzoylurea.
1 6. A process as claimed in Claim 1, when used to prepare 1 -(1 -benzylpiperid-4-yl)-3-(3methoxybenzyl)urea.
1 7. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-(1 -[2-(indol-3 yl)ethyl]piperid-4-yl)urea.
1 8. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-( 1 -[4-oxo-4phenylbutyl]piperid-4-yl)urea.
1 9. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-(1 -[indol-3 ylmethyl]piperid-4-yI)urea.
20. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-[1 -(2-indol-3-yl- ethyl)piperid-4-yl]thiourea.
21. A process as claimed in Claim 1, when used to prepare 1-(2-thenoyl)-3-[1-(2 [indolyl]ethyl)piperid-4-yl] urea.
22. A process as claimed in Claim 1, when used to prepare 1-cyclohexane carbonyl-3-[1-(2-[3indolyl]ethyl)piperid-4-yl]urea.
23. A process as claimed in Claim 1, when used to prepare 1-(4-chlorobenzoyl)-3-(1-[indol-3- ylmethyl]piperid-4-yl)urea.
24. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-[1 -(2-( 1 ,4-benzodioxan-2- yl)-2-oxoethyl] piperid-4-yl] urea.
25. A process as claimed in Claim 1, when used to prepare 1 -benzoyl-3-[1 -(2-hydroxy-3-[2- methoxyphenoxy]propyl)-piperid-4-yl] urea.
26. A process as claimed in any one of the preceding claims when carried out by heating the reactants in an inert organic solvent which has a boiling point above 1 0O0C.
27. A process as claimed in Claim 26, wherein the solvent is pyridine.
28. A process as claimed in Claim 26, wherein the solvent is toluene.
29. A process as claimed in any one of claims 26 to 28, when carried out under reflux.
30. A process as claimed in Claim 1, substantially as herein before described in any one of Examples 1 to 12.
31. A compound of formula I whenever prepared by a process as claimed in any one of the preceding claims.
GB7936701A 1978-10-24 1979-10-23 Preparation of piperidine derivatives Expired GB2034305B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE2100/78A IE47461B1 (en) 1977-12-01 1978-10-24 Indole derivatives, their preparation and use in pharmaceutical compositions

Publications (2)

Publication Number Publication Date
GB2034305A true GB2034305A (en) 1980-06-04
GB2034305B GB2034305B (en) 1982-12-22

Family

ID=11032790

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7936701A Expired GB2034305B (en) 1978-10-24 1979-10-23 Preparation of piperidine derivatives

Country Status (1)

Country Link
GB (1) GB2034305B (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0035374A2 (en) * 1980-03-01 1981-09-09 JOHN WYETH &amp; BROTHER LIMITED Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives
WO1983004022A1 (en) * 1982-05-18 1983-11-24 Bouchara, Emile New phenyloxoalkyl piperidines, methods for obtaining them and pharmaceutical compositions containing them
WO1985001288A1 (en) * 1983-09-19 1985-03-28 Bouchara, Emile New substituted piperidinoguanidines, preparation process and pharmaceutical compositions containing them
EP0228795A1 (en) * 1985-11-15 1987-07-15 JOHN WYETH &amp; BROTHER LIMITED Piperidine derivatives having a psychotropic activity
EP0234098A1 (en) * 1985-11-15 1987-09-02 JOHN WYETH &amp; BROTHER LIMITED N-[piperidylaminocarbonyl]quinolinecarboxamide derivatives having psychotropic activity
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
WO2005000826A1 (en) * 2003-06-23 2005-01-06 Cv Therapeutics, Inc. Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
WO2005061470A1 (en) * 2003-12-18 2005-07-07 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
EP0035374A3 (en) * 1980-03-01 1981-11-11 John Wyeth & Brother Limited Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives
EP0035374A2 (en) * 1980-03-01 1981-09-09 JOHN WYETH &amp; BROTHER LIMITED Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives
US5212179A (en) * 1980-03-01 1993-05-18 John Wyeth And Brother Limited Piperidine derivatives
US4985438A (en) * 1980-03-01 1991-01-15 John Wyeth & Brother, Limited Pyridyl-and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
WO1983004022A1 (en) * 1982-05-18 1983-11-24 Bouchara, Emile New phenyloxoalkyl piperidines, methods for obtaining them and pharmaceutical compositions containing them
WO1985001288A1 (en) * 1983-09-19 1985-03-28 Bouchara, Emile New substituted piperidinoguanidines, preparation process and pharmaceutical compositions containing them
US4778802A (en) * 1985-11-15 1988-10-18 John Wyeth & Brother, Ltd. Heterocyclic compounds
EP0234098A1 (en) * 1985-11-15 1987-09-02 JOHN WYETH &amp; BROTHER LIMITED N-[piperidylaminocarbonyl]quinolinecarboxamide derivatives having psychotropic activity
EP0228795A1 (en) * 1985-11-15 1987-07-15 JOHN WYETH &amp; BROTHER LIMITED Piperidine derivatives having a psychotropic activity
WO2005000826A1 (en) * 2003-06-23 2005-01-06 Cv Therapeutics, Inc. Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
US7208496B2 (en) 2003-06-23 2007-04-24 Cv Therapeutics, Inc. Substituted heterocyclic compounds
JP2007518677A (en) * 2003-06-23 2007-07-12 シーブイ・セラピューティクス・インコーポレイテッド Piperazine and urea derivatives of piperidine as fatty acid oxidation inhibitors
WO2005061470A1 (en) * 2003-12-18 2005-07-07 Cv Therapeutics, Inc. 1-akan-2-ol substituted piperazine and piperidine compounds
US7115610B2 (en) 2003-12-18 2006-10-03 Cv Therapeutics, Inc. Substituted heterocyclic compounds

Also Published As

Publication number Publication date
GB2034305B (en) 1982-12-22

Similar Documents

Publication Publication Date Title
EP0244176A2 (en) Thienopyrimidine-2,4-dione derivatives and intermediates thereof
SE449748B (en) 2- (4 - ((4,4-DIALKYL-2,6-PIPERIDINDION-1-YL) BUTYL) -1-PIPERAZINYL) PYRIDINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION
GB2034305A (en) Preparation of piperidine derivatives
US4436913A (en) 1H- and 2H- indazole derivatives
HU193501B (en) Process for preparing substututed 2-amino-benzimidazoles
MX2007015876A (en) Methods and intermediates for the preparation of optionally radio-labeled imatinib.
NO130329B (en)
HU191682B (en) Process for preparing 1-benzyl-azetidin-3-ol derivatives
SE450120B (en) NEW DIMETOXICINAZOLINE DERIVATIVES TO USE FOR PREPARATION OF 2 (4-SUBSTITUTED PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXICINAZOLINES
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US3393208A (en) 6h-benzo[5, 6] cyclohept[1, 2, 3-cd]indolin-1, 6-diones
US3433802A (en) 3-(n-lower-alkylanilino)pyrrolidines
ATE259353T1 (en) PROPENONE DERIVATIVES
US4140691A (en) Process for preparing 3-[2-(4-benzamidopiperid-1-yl)ethyl]indole
KR920009884B1 (en) 2,3-thiomorpholinedione-2-oxime derivatives and process for preparing same
HU182272B (en) Process for preparing rhanitidine
US2996506A (en) Hcxchb
SU920056A1 (en) Method of producing r,s-2,3,5,6-tetrahydro-6-phenilimidazo(2,1)-thiazole
PL153449B1 (en) Procedure for the production of mercaptoacyloproline
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
US4162252A (en) Process for preparing 3-[(benzamidopiperid-1-yl)alkyl] indoles
EP0046694A1 (en) Preparation of thiophenes
CA1201123A (en) Process for the preparation of sulphoximines
KR810000888B1 (en) Process for preparing indoles derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951023